SYNLAB AG
ISIN: DE000A2TSL71 | Ticker: SYAB | LEI: 984500883BA5AQ14C037
Country: Germany
SYNLAB offers a full range of medical diagnostic services for practising doctors, clinics and patients.
The SYNLAB Group is the uncontested leader on the European market for human medicine laboratory services. SYNLAB particularly focuses on the implementation of innovative laboratory medicine methods and on networking specialist diagnostic competences (SYNLAB Centres of Excellence).
SYNLAB maintains additional laboratories (strategic business units) in individual countries for veterinary medicine. This services portfolio is rounded off by expert medical imaging centres, day clinics and ambulatory services in certain countries.
The group works closely with research institutions and universities and also maintains an educational institution of its own, the SYNLAB Academy.
2010
Served areaWorldwide
Headcount30,570
HeadquartersMoosacher Straße 88, 80809 München – Germany
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 02.10.23 | Ebsworth GmbH | Close relation | Sell | EUR 107,484.01 |
| 02.10.23 | Ebsworth GmbH | Close relation | Sell | EUR 7,140.00 |
| 10.05.22 | Henkel, Dr. Holger | Supervisory board | Other | EUR 0.00 |
| 04.05.22 | Riedel, Oliver | Board | Buy | EUR 5,800.00 |
| 02.05.22 | Schmitt, Martin | Supervisory board | Buy | EUR 1,071.00 |
| 21.12.21 | Lorenz-Meyer, Robert | Supervisory board | Sell | EUR 8,960.90 |
DE000A2TSL71
LEI984500883BA5AQ14C037
SectorHealth Care Equipment & Services
IndustryHealth Care Providers & Services
Sub-IndustryGoldman Sachs Bank Europe SE
J. P. Morgan AG
Listed Stock ExchangeSDAX
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.